Ovarian Cancer Clinical Trials

Review the ovarian cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 301-319 of 319

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Status: Active
Location: 9 locations
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Status: Active
Location: 8 locations
Responses to Genetic Risk Modifier Testing among Women with BRCA1/2 Mutations
Status: Active
Location: 7 locations
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Status: Active
Location: 5 locations
Polygenic Risk Scores and Multi-cancer Early Detection for Ovarian Cancer (PROMISE Study)
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
Status: Active
Location: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama
Understanding the Experience of Ovarian Cancer-Life after Diagnosis, UNTOLD Study
Status: Active
Location: University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Status: Active
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Northwestern Ovarian Cancer Early Detection and Prevention Program
Status: Active
Location: Northwestern University, Chicago, Illinois
Data Collection for Patients with Low Grade Ovarian or Peritoneal Tumors
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
International Ovarian & Testicular Stromal Tumor Registry
Status: Active
Location: Dana-Farber Cancer Institute, Boston, Massachusetts
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients with Cancers, CHANCES Study
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Paclitaxel Monitoring in Patients with Solid Tumors
Status: Active
Location: Wake Forest University Health Sciences, Winston-Salem, North Carolina
Rapid Autopsy and Procurement of Cancer Tissue
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Breast Cancer Liquid Biopsy Trial
Status: Active
Location: See ClinicalTrials.gov
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
Status: Enrolling by Invitation
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Status: Temporarily Closed to Accrual
Location: See ClinicalTrials.gov